G33532XU
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
RES 1b:x-dgal-HEX-1:5 2b:b-dglc-HEX-1:5 3s:n-acetyl 4b:b-dgal-HEX-1:5 5b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 6s:n-acetyl 7b:b-dgal-HEX-1:5 8s:n-acetyl 9b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 10s:n-acetyl LIN 1:1o(3+1)2d 2:2d(2+1)3n 3:2o(3+1)4d 4:4o(3+2)5d 5:5d(5+1)6n 6:4o(4+1)7d 7:7d(2+1)8n 8:2o(6+2)9d 9:9d(5+1)10n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 15704108 | RM2 antigen (beta1,4-GalNAc-disialyl-Lc4) as a new marker for prostate cancer | Saito S | 2005 May 20 |
|
| 11278988 | A novel ganglioside isolated from renal cell carcinoma | Ito A | 2001 May 18 |
|
| 12084983 | Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues | Ito A | 2001 Jun |
|
| 7509790 | Common tetrasaccharide epitope NeuAc alpha 2-->3Gal beta 1-->3(Neu-Ac alpha 2-->6)GalNAc, presented by different carrier glycosylceramides or O-linked peptides, is recognized by different antibodies and ligands having distinct specificities | Saito S | 1994 Feb 25 |
|
| Title | Authors | Source | Publication Date | PubMed ID |
|---|---|---|---|---|
| Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells. |
|
Sci Rep | 2018 May 4 | 29728594 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025